Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Fischinger

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
Mbio|August 24, 2022
Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced ImmunityKathryn A Bowman, Daniel Stein, Sally Shin, et al.
Ebiomedicine|October 10, 2020
An observational study identifying highly tuberculosis-exposed, HIV-1-positive but persistently TB, tuberculin and IGRA negative persons with M. tuberculosis specific antibodies in Cape Town, South AfricaElouise E Kroon, Craig J Kinnear, Marianna Orlova, et al.
Hepatology Communications|September 23, 2021
Liver Fibrosis Index FIB-4 Is Associated With Mortality in COVID-19Yijia Li, James Regan, Jesse Fajnzylber, et al.
JCI Insight|June 20, 2020
Protein-based, but not viral vector alone, HIV vaccine boosting drives an IgG1-biased polyfunctional humoral immune responseStephanie Fischinger, Sally Shin, Carolyn M Boudreau, et al.
Plos One|April 12, 2022
Serological testing for SARS-CoV-2 antibodies of employees shows low transmission working in a cancer centerJeffrey A Meyerhardt, Hong Yue, Radosław P Nowak, et al.
Medrxiv : the Preprint Server for Health Sciences|September 10, 2020
Rapid 'mix and read' assay for scalable detection of SARS-CoV-2 antibodies in patient plasmaHong Yue, Radosław P Nowak, Daan Overwijn, et al.
Plos Pathogens|November 29, 2021
Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trialsStephanie Fischinger, Deniz Cizmeci, Davy Deng, et al.
Medrxiv : the Preprint Server for Health Sciences|July 2, 2020
Evaluation of two commercial and two non-commercial immunoassays for the detection of prior infection to SARS-CoV-2Eric J Nilles, Elizabeth W Karlson, Maia Norman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 25, 2022
Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence in Massachusetts Estimated from Newborn Screening SpecimensKevin C Ma, Jaime E Hale, Yonatan H Grad, et al.
Mbio|June 28, 2022
The Kinetics of SARS-CoV-2 Antibody Development Is Associated with Clearance of RNAemiaChuangqi Wang, Yijia Li, Paulina Kaplonek, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Mbio|August 24, 2022
Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced ImmunityKathryn A Bowman, Daniel Stein, Sally Shin, et al.
Ebiomedicine|October 10, 2020
An observational study identifying highly tuberculosis-exposed, HIV-1-positive but persistently TB, tuberculin and IGRA negative persons with M. tuberculosis specific antibodies in Cape Town, South AfricaElouise E Kroon, Craig J Kinnear, Marianna Orlova, et al.
Hepatology Communications|September 23, 2021
Liver Fibrosis Index FIB-4 Is Associated With Mortality in COVID-19Yijia Li, James Regan, Jesse Fajnzylber, et al.
JCI Insight|June 20, 2020
Protein-based, but not viral vector alone, HIV vaccine boosting drives an IgG1-biased polyfunctional humoral immune responseStephanie Fischinger, Sally Shin, Carolyn M Boudreau, et al.
Plos One|April 12, 2022
Serological testing for SARS-CoV-2 antibodies of employees shows low transmission working in a cancer centerJeffrey A Meyerhardt, Hong Yue, Radosław P Nowak, et al.
Medrxiv : the Preprint Server for Health Sciences|September 10, 2020
Rapid 'mix and read' assay for scalable detection of SARS-CoV-2 antibodies in patient plasmaHong Yue, Radosław P Nowak, Daan Overwijn, et al.
Plos Pathogens|November 29, 2021
Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trialsStephanie Fischinger, Deniz Cizmeci, Davy Deng, et al.
Medrxiv : the Preprint Server for Health Sciences|July 2, 2020
Evaluation of two commercial and two non-commercial immunoassays for the detection of prior infection to SARS-CoV-2Eric J Nilles, Elizabeth W Karlson, Maia Norman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 25, 2022
Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence in Massachusetts Estimated from Newborn Screening SpecimensKevin C Ma, Jaime E Hale, Yonatan H Grad, et al.
Mbio|June 28, 2022
The Kinetics of SARS-CoV-2 Antibody Development Is Associated with Clearance of RNAemiaChuangqi Wang, Yijia Li, Paulina Kaplonek, et al.
Pageof 8